SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Drug Royalty Corporation (DRI-TSE) -- Ignore unavailable to you. Want to Upgrade?


To: AL R who wrote (82)3/25/1999 9:06:00 PM
From: Drapeau  Read Replies (1) | Respond to of 96
 
From the investor point of view, can someone explains me why I would buy the warrant at 2.25$ rather than the share at 2.20$.

"...at a purchase price per special warrant of $2.25 for
gross proceeds of $16,425,000."

"Once released to the Company, the net proceeds..."

Why this emission is called a "private placement". I understand that Yorkton Securities Inc. and HSBC James Capel Canada Inc. will have some remuneration to sell the warrants to individuals.

--
Drapeau